APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Urokinase Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Urokinase Injection Market Analysis and Forecast 2026-2032

Report ID 174044640219 December 2025190 pages

Choose your research edition.

Industry ResearchUrokinase Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Urokinase Injection Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Urokinase Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urokinase Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Urokinase Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Urokinase Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Urokinase Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Urokinase Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Urokinase Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Urokinase Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Urokinase Injection include NDPHARM, Microbic Biosystems Inc, Techpool, Jiangsu Aidea Pharmaceutical, Jiangxi Haoran Bio-Pharma, LIVZON and Wanhua Biochem, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Urokinase Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Urokinase Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Urokinase Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Urokinase Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Urokinase Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Urokinase Injection sales, projected growth trends, production technology, application and end-user industry.

Urokinase Injection Segment by Company

NDPHARM

Microbic Biosystems Inc

Techpool

Jiangsu Aidea Pharmaceutical

Jiangxi Haoran Bio-Pharma

LIVZON

Wanhua Biochem

Urokinase Injection Segment by Type

10000-100000IU

100000-1000000IU

Others

Urokinase Injection Segment by Application

Hospital

Clinic

Others

Urokinase Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urokinase Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urokinase Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urokinase Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Urokinase Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Urokinase Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urokinase Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Urokinase Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10000-100000IU Major Manufacturers Table 3. 100000-1000000IU Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Urokinase Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Others Major Manufacturers Table 9. Urokinase Injection Industry Trends Table 10. Urokinase Injection Industry Drivers Table 11. Urokinase Injection Industry Opportunities and Challenges Table 12. Urokinase Injection Industry Restraints Table 13. Global Urokinase Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Urokinase Injection Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Urokinase Injection Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Urokinase Injection Revenue Market Share by Region (2021-2026) Table 17. Global Urokinase Injection Revenue Market Share by Region (2027-2032) Table 18. Global Urokinase Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Urokinase Injection Sales by Region (2021-2026) & (K Units) Table 20. Global Urokinase Injection Sales by Region (2027-2032) & (K Units) Table 21. Global Urokinase Injection Sales Market Share by Region (2021-2026) Table 22. Global Urokinase Injection Sales Market Share by Region (2027-2032) Table 23. Global Urokinase Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Urokinase Injection Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Urokinase Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Urokinase Injection Sales Market Share by Manufacturers (2021-2026) Table 27. Global Urokinase Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Urokinase Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Urokinase Injection Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Urokinase Injection Manufacturers, Product Type & Application Table 31. Global Urokinase Injection Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Urokinase Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Urokinase Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Urokinase Injection Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Urokinase Injection Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Urokinase Injection Revenue Market Share by Type (2021-2026) Table 38. Global Urokinase Injection Revenue Market Share by Type (2027-2032) Table 39. Global Urokinase Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 41. Global Urokinase Injection Sales by Type (2027-2032) & (K Units) Table 42. Global Urokinase Injection Sales Market Share by Type (2021-2026) Table 43. Global Urokinase Injection Sales Market Share by Type (2027-2032) Table 44. Global Urokinase Injection Price by Type (2021-2026) & (US$/Unit) Table 45. Global Urokinase Injection Price by Type (2027-2032) & (US$/Unit) Table 46. Global Urokinase Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Urokinase Injection Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Urokinase Injection Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Urokinase Injection Revenue Market Share by Application (2021-2026) Table 50. Global Urokinase Injection Revenue Market Share by Application (2027-2032) Table 51. Global Urokinase Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Urokinase Injection Sales by Application (2027-2032) & (K Units) Table 54. Global Urokinase Injection Sales Market Share by Application (2021-2026) Table 55. Global Urokinase Injection Sales Market Share by Application (2027-2032) Table 56. Global Urokinase Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Urokinase Injection Price by Application (2027-2032) & (US$/Unit) Table 58. NDPHARM Company Information Table 59. NDPHARM Business Overview Table 60. NDPHARM Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. NDPHARM Urokinase Injection Product Portfolio Table 62. NDPHARM Recent Development Table 63. Microbic Biosystems Inc Company Information Table 64. Microbic Biosystems Inc Business Overview Table 65. Microbic Biosystems Inc Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Microbic Biosystems Inc Urokinase Injection Product Portfolio Table 67. Microbic Biosystems Inc Recent Development Table 68. Techpool Company Information Table 69. Techpool Business Overview Table 70. Techpool Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Techpool Urokinase Injection Product Portfolio Table 72. Techpool Recent Development Table 73. Jiangsu Aidea Pharmaceutical Company Information Table 74. Jiangsu Aidea Pharmaceutical Business Overview Table 75. Jiangsu Aidea Pharmaceutical Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Jiangsu Aidea Pharmaceutical Urokinase Injection Product Portfolio Table 77. Jiangsu Aidea Pharmaceutical Recent Development Table 78. Jiangxi Haoran Bio-Pharma Company Information Table 79. Jiangxi Haoran Bio-Pharma Business Overview Table 80. Jiangxi Haoran Bio-Pharma Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Jiangxi Haoran Bio-Pharma Urokinase Injection Product Portfolio Table 82. Jiangxi Haoran Bio-Pharma Recent Development Table 83. LIVZON Company Information Table 84. LIVZON Business Overview Table 85. LIVZON Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. LIVZON Urokinase Injection Product Portfolio Table 87. LIVZON Recent Development Table 88. Wanhua Biochem Company Information Table 89. Wanhua Biochem Business Overview Table 90. Wanhua Biochem Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Wanhua Biochem Urokinase Injection Product Portfolio Table 92. Wanhua Biochem Recent Development Table 93. North America Urokinase Injection Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Urokinase Injection Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 96. North America Urokinase Injection Sales by Type (2027-2032) & (K Units) Table 97. North America Urokinase Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 98. North America Urokinase Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 99. North America Urokinase Injection Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Urokinase Injection Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 102. North America Urokinase Injection Sales by Application (2027-2032) & (K Units) Table 103. North America Urokinase Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 104. North America Urokinase Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 105. North America Urokinase Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Urokinase Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Urokinase Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Urokinase Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 109. North America Urokinase Injection Sales by Country (2021-2026) & (K Units) Table 110. North America Urokinase Injection Sales by Country (2027-2032) & (K Units) Table 111. North America Urokinase Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 112. North America Urokinase Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 113. United States Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 114. Canada Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 115. Europe Urokinase Injection Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Urokinase Injection Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 118. Europe Urokinase Injection Sales by Type (2027-2032) & (K Units) Table 119. Europe Urokinase Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 120. Europe Urokinase Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 121. Europe Urokinase Injection Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Urokinase Injection Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 124. Europe Urokinase Injection Sales by Application (2027-2032) & (K Units) Table 125. Europe Urokinase Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 126. Europe Urokinase Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 127. Europe Urokinase Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Urokinase Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Urokinase Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Urokinase Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 131. Europe Urokinase Injection Sales by Country (2021-2026) & (K Units) Table 132. Europe Urokinase Injection Sales by Country (2027-2032) & (K Units) Table 133. Europe Urokinase Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 134. Europe Urokinase Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 135. Germany Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 136. France Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 137. U.K. Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 138. Italy Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 139. Netherlands Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 140. China Urokinase Injection Revenue by Type (2021-2026) & (US$ Million) Table 141. China Urokinase Injection Revenue by Type (2027-2032) & (US$ Million) Table 142. China Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 143. China Urokinase Injection Sales by Type (2027-2032) & (K Units) Table 144. China Urokinase Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 145. China Urokinase Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 146. China Urokinase Injection Revenue by Application (2021-2026) & (US$ Million) Table 147. China Urokinase Injection Revenue by Application (2027-2032) & (US$ Million) Table 148. China Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 149. China Urokinase Injection Sales by Application (2027-2032) & (K Units) Table 150. China Urokinase Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 151. China Urokinase Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Asia Urokinase Injection Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Urokinase Injection Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 155. Asia Urokinase Injection Sales by Type (2027-2032) & (K Units) Table 156. Asia Urokinase Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 157. Asia Urokinase Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 158. Asia Urokinase Injection Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Urokinase Injection Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 161. Asia Urokinase Injection Sales by Application (2027-2032) & (K Units) Table 162. Asia Urokinase Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 163. Asia Urokinase Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Urokinase Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Urokinase Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Urokinase Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Urokinase Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. Asia Urokinase Injection Sales by Country (2021-2026) & (K Units) Table 169. Asia Urokinase Injection Sales by Country (2027-2032) & (K Units) Table 170. Asia Urokinase Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 171. Asia Urokinase Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Japan Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 173. South Korea Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 174. India Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 175. Australia Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 176. China Taiwan Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Urokinase Injection Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Urokinase Injection Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 181. SAMEA Urokinase Injection Sales by Type (2027-2032) & (K Units) Table 182. SAMEA Urokinase Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 183. SAMEA Urokinase Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 184. SAMEA Urokinase Injection Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Urokinase Injection Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 187. SAMEA Urokinase Injection Sales by Application (2027-2032) & (K Units) Table 188. SAMEA Urokinase Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 189. SAMEA Urokinase Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 190. SAMEA Urokinase Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Urokinase Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Urokinase Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Urokinase Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 194. SAMEA Urokinase Injection Sales by Country (2021-2026) & (K Units) Table 195. SAMEA Urokinase Injection Sales by Country (2027-2032) & (K Units) Table 196. SAMEA Urokinase Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 197. SAMEA Urokinase Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 198. Brazil Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 199. Argentina Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 200. Chile Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 201. Colombia Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 202. Peru Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 204. Israel Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 205. UAE Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 206. Turkey Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 207. Iran Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 208. Egypt Urokinase Injection Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Urokinase Injection Distributors List Table 212. Urokinase Injection Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Urokinase Injection Image Figure 2. Global Urokinase Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urokinase Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10000-100000IU Image Figure 5. 100000-1000000IU Image Figure 6. Others Image Figure 7. Global Urokinase Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Urokinase Injection Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Others Image Figure 12. Global Urokinase Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Urokinase Injection Revenue (2021-2032) & (US$ Million) Figure 14. Global Urokinase Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Urokinase Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Urokinase Injection Revenue Market Share by Region (2021-2032) Figure 17. Global Urokinase Injection Sales (2021-2032) & (K Units) Figure 18. Global Urokinase Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Urokinase Injection Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Urokinase Injection Sales YoY (2021-2032) & (K Units) Figure 21. Europe Urokinase Injection Sales YoY (2021-2032) & (K Units) Figure 22. China Urokinase Injection Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Urokinase Injection Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Urokinase Injection Sales YoY (2021-2032) & (K Units) Figure 25. Global Urokinase Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Urokinase Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Urokinase Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Urokinase Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Urokinase Injection Revenue Market Share by Type (2021-2032) Figure 31. Global Urokinase Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Urokinase Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Urokinase Injection Sales Market Share by Type (2021-2032) Figure 34. Global Urokinase Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Urokinase Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Urokinase Injection Revenue Market Share by Application (2021-2032) Figure 37. Global Urokinase Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Urokinase Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Urokinase Injection Sales Market Share by Application (2021-2032) Figure 40. North America Urokinase Injection Revenue Share by Type (2021-2032) Figure 41. North America Urokinase Injection Sales Share by Type (2021-2032) Figure 42. North America Urokinase Injection Revenue Share by Application (2021-2032) Figure 43. North America Urokinase Injection Sales Share by Application (2021-2032) Figure 44. North America Urokinase Injection Revenue Share by Country (2021-2032) Figure 45. North America Urokinase Injection Sales Share by Country (2021-2032) Figure 46. Europe Urokinase Injection Revenue Share by Type (2021-2032) Figure 47. Europe Urokinase Injection Sales Share by Type (2021-2032) Figure 48. Europe Urokinase Injection Revenue Share by Application (2021-2032) Figure 49. Europe Urokinase Injection Sales Share by Application (2021-2032) Figure 50. Europe Urokinase Injection Revenue Share by Country (2021-2032) Figure 51. Europe Urokinase Injection Sales Share by Country (2021-2032) Figure 52. China Urokinase Injection Revenue Share by Type (2021-2032) Figure 53. China Urokinase Injection Sales Share by Type (2021-2032) Figure 54. China Urokinase Injection Revenue Share by Application (2021-2032) Figure 55. China Urokinase Injection Sales Share by Application (2021-2032) Figure 56. Asia Urokinase Injection Revenue Share by Type (2021-2032) Figure 57. Asia Urokinase Injection Sales Share by Type (2021-2032) Figure 58. Asia Urokinase Injection Revenue Share by Application (2021-2032) Figure 59. Asia Urokinase Injection Sales Share by Application (2021-2032) Figure 60. Asia Urokinase Injection Revenue Share by Country (2021-2032) Figure 61. Asia Urokinase Injection Sales Share by Country (2021-2032) Figure 62. SAMEA Urokinase Injection Revenue Share by Type (2021-2032) Figure 63. SAMEA Urokinase Injection Sales Share by Type (2021-2032) Figure 64. SAMEA Urokinase Injection Revenue Share by Application (2021-2032) Figure 65. SAMEA Urokinase Injection Sales Share by Application (2021-2032) Figure 66. SAMEA Urokinase Injection Revenue Share by Country (2021-2032) Figure 67. SAMEA Urokinase Injection Sales Share by Country (2021-2032) Figure 68. Urokinase Injection Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Urokinase Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 10000-100000IU
  • 100000-1000000IU
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • NDPHARM
  • Microbic Biosystems Inc
  • Techpool
  • Jiangsu Aidea Pharmaceutical
  • Jiangxi Haoran Bio-Pharma
  • LIVZON
  • Wanhua Biochem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Urokinase Injection Market by Type
  3. 1.2.1 Global Urokinase Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10000-100000IU
  5. 1.2.3 100000-1000000IU
  6. 1.2.4 Others
  7. 1.3 Urokinase Injection Market by Application
  8. 1.3.1 Global Urokinase Injection Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Urokinase Injection Market Dynamics
  1. 2.1 Urokinase Injection Industry Trends
  2. 2.2 Urokinase Injection Industry Drivers
  3. 2.3 Urokinase Injection Industry Opportunities and Challenges
  4. 2.4 Urokinase Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Urokinase Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Urokinase Injection Revenue by Region
  3. 3.2.1 Global Urokinase Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Urokinase Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Urokinase Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Urokinase Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Urokinase Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Urokinase Injection Sales by Region
  9. 3.4.1 Global Urokinase Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Urokinase Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Urokinase Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Urokinase Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Urokinase Injection Revenue by Manufacturers
  2. 4.1.1 Global Urokinase Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Urokinase Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Urokinase Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Urokinase Injection Sales by Manufacturers
  6. 4.2.1 Global Urokinase Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Urokinase Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Urokinase Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Urokinase Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Urokinase Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Urokinase Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Urokinase Injection Manufacturers, Product Type & Application
  13. 4.7 Global Urokinase Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Urokinase Injection Market CR5 and HHI
  16. 4.8.2 2025 Urokinase Injection Tier 1, Tier 2, and Tier 3
5 Urokinase Injection Market by Type
  1. 5.1 Global Urokinase Injection Revenue by Type
  2. 5.1.1 Global Urokinase Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Urokinase Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Urokinase Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Urokinase Injection Sales by Type
  6. 5.2.1 Global Urokinase Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Urokinase Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Urokinase Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Urokinase Injection Price by Type
6 Urokinase Injection Market by Application
  1. 6.1 Global Urokinase Injection Revenue by Application
  2. 6.1.1 Global Urokinase Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Urokinase Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Urokinase Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Urokinase Injection Sales by Application
  6. 6.2.1 Global Urokinase Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Urokinase Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Urokinase Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Urokinase Injection Price by Application
7 Company Profiles
  1. 7.1 NDPHARM
  2. 7.1.1 NDPHARM Company Information
  3. 7.1.2 NDPHARM Business Overview
  4. 7.1.3 NDPHARM Urokinase Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 NDPHARM Urokinase Injection Product Portfolio
  6. 7.1.5 NDPHARM Recent Developments
  7. 7.2 Microbic Biosystems Inc
  8. 7.2.1 Microbic Biosystems Inc Company Information
  9. 7.2.2 Microbic Biosystems Inc Business Overview
  10. 7.2.3 Microbic Biosystems Inc Urokinase Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Microbic Biosystems Inc Urokinase Injection Product Portfolio
  12. 7.2.5 Microbic Biosystems Inc Recent Developments
  13. 7.3 Techpool
  14. 7.3.1 Techpool Company Information
  15. 7.3.2 Techpool Business Overview
  16. 7.3.3 Techpool Urokinase Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Techpool Urokinase Injection Product Portfolio
  18. 7.3.5 Techpool Recent Developments
  19. 7.4 Jiangsu Aidea Pharmaceutical
  20. 7.4.1 Jiangsu Aidea Pharmaceutical Company Information
  21. 7.4.2 Jiangsu Aidea Pharmaceutical Business Overview
  22. 7.4.3 Jiangsu Aidea Pharmaceutical Urokinase Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Jiangsu Aidea Pharmaceutical Urokinase Injection Product Portfolio
  24. 7.4.5 Jiangsu Aidea Pharmaceutical Recent Developments
  25. 7.5 Jiangxi Haoran Bio-Pharma
  26. 7.5.1 Jiangxi Haoran Bio-Pharma Company Information
  27. 7.5.2 Jiangxi Haoran Bio-Pharma Business Overview
  28. 7.5.3 Jiangxi Haoran Bio-Pharma Urokinase Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jiangxi Haoran Bio-Pharma Urokinase Injection Product Portfolio
  30. 7.5.5 Jiangxi Haoran Bio-Pharma Recent Developments
  31. 7.6 LIVZON
  32. 7.6.1 LIVZON Company Information
  33. 7.6.2 LIVZON Business Overview
  34. 7.6.3 LIVZON Urokinase Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 LIVZON Urokinase Injection Product Portfolio
  36. 7.6.5 LIVZON Recent Developments
  37. 7.7 Wanhua Biochem
  38. 7.7.1 Wanhua Biochem Company Information
  39. 7.7.2 Wanhua Biochem Business Overview
  40. 7.7.3 Wanhua Biochem Urokinase Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Wanhua Biochem Urokinase Injection Product Portfolio
  42. 7.7.5 Wanhua Biochem Recent Developments
8 North America
  1. 8.1 North America Urokinase Injection Market Size by Type
  2. 8.1.1 North America Urokinase Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Urokinase Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Urokinase Injection Price by Type (2021-2032)
  5. 8.2 North America Urokinase Injection Market Size by Application
  6. 8.2.1 North America Urokinase Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Urokinase Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Urokinase Injection Price by Application (2021-2032)
  9. 8.3 North America Urokinase Injection Market Size by Country
  10. 8.3.1 North America Urokinase Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Urokinase Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Urokinase Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Urokinase Injection Market Size by Type
  2. 9.1.1 Europe Urokinase Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Urokinase Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Urokinase Injection Price by Type (2021-2032)
  5. 9.2 Europe Urokinase Injection Market Size by Application
  6. 9.2.1 Europe Urokinase Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Urokinase Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Urokinase Injection Price by Application (2021-2032)
  9. 9.3 Europe Urokinase Injection Market Size by Country
  10. 9.3.1 Europe Urokinase Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Urokinase Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Urokinase Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Urokinase Injection Market Size by Type
  2. 10.1.1 China Urokinase Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Urokinase Injection Sales by Type (2021-2032)
  4. 10.1.3 China Urokinase Injection Price by Type (2021-2032)
  5. 10.2 China Urokinase Injection Market Size by Application
  6. 10.2.1 China Urokinase Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Urokinase Injection Sales by Application (2021-2032)
  8. 10.2.3 China Urokinase Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Urokinase Injection Market Size by Type
  2. 11.1.1 Asia Urokinase Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Urokinase Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Urokinase Injection Price by Type (2021-2032)
  5. 11.2 Asia Urokinase Injection Market Size by Application
  6. 11.2.1 Asia Urokinase Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Urokinase Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Urokinase Injection Price by Application (2021-2032)
  9. 11.3 Asia Urokinase Injection Market Size by Country
  10. 11.3.1 Asia Urokinase Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Urokinase Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Urokinase Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Urokinase Injection Market Size by Type
  2. 12.1.1 SAMEA Urokinase Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Urokinase Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Urokinase Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Urokinase Injection Market Size by Application
  6. 12.2.1 SAMEA Urokinase Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Urokinase Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Urokinase Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Urokinase Injection Market Size by Country
  10. 12.3.1 SAMEA Urokinase Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Urokinase Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Urokinase Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Urokinase Injection Value Chain Analysis
  2. 13.1.1 Urokinase Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Urokinase Injection Production Mode & Process
  6. 13.2 Urokinase Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Urokinase Injection Distributors
  9. 13.2.3 Urokinase Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst